-
Innovation Ranking
NewInnovation Ranking – Revolution Medicines Inc
Revolution Medicines Inc (Revolution Medicines) is a clinical-stage precision oncology company that discover and developed medicines and therapies for cancer patients. The company product candidate is RMC-4630, a clinical-stage drug candidate that potently and selectively inhibits SHP2, a central node in the RAS signaling pathway. Its other product includes RMC-4630, RMC-5552, SOS1. Revolution Medicines also provide a research and development pipeline comprising RAS(ON) inhibitors that bind directly to RAS variants. The company partners with pharmaceutical companies and healthcare organizations for...
-
Product Insights
NewNet Present Value Model: Revolution Medicines Inc’s RMC-6291
Empower your strategies with our Net Present Value Model: Revolution Medicines Inc's RMC-6291 report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewNet Present Value Model: Revolution Medicines Inc’s RMC-6236
Empower your strategies with our Net Present Value Model: Revolution Medicines Inc's RMC-6236 report and make more profitable business decisions.Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
Eversource Energy/ Orsted US Offshore Wind – Revolution Wind Farm 704 MW – Rhode Island
The Eversource Energy/ Orsted US Offshore Wind – Revolution Wind Farm 704 MW – Rhode Island project involves the construction of a 704MW off-shore wind farm in Rhode Island, the US. Equip yourself with the essential tools needed to make informed and profitable decisions with our Eversource Energy/ Orsted US Offshore Wind – Revolution Wind Farm 704 MW – Rhode Island report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within...
-
Product Insights
Revolution Wind Farm
Revolution Wind Farm is an offshore wind project located in Atlantic Ocean, United States. The project is owned by Eversource Energy; Orsted US Offshore Wind and is developed by DWW Rev I LLC. The project is at the permitting stage. Empower your strategies with our Revolution Wind Farm report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the...
-
Product Insights
Revolution Wind 2
Revolution Wind 2 is an offshore wind project located in Atlantic Ocean, United States. The project is owned and being developed by Eversource Energy; Orsted US Offshore Wind. The project is expected to come online in 2029. Empower your strategies with our Revolution Wind 2 report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends...
-
Product Insights
NewNet Present Value Model: Revolution Medicines Inc’s RMC-4630
Empower your strategies with our Net Present Value Model: Revolution Medicines Inc's RMC-4630 report and make more profitable business decisions.Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewNet Present Value Model: Revolution Medicines Inc’s RMC-6291
Empower your strategies with our Net Present Value Model: Revolution Medicines Inc's RMC-6291 report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Company Insights
Innovation and Patenting activity of Revolution Medicines Inc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Revolution Medicines Inc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Sector Analysis
NewEgypt Defense Market Size, Trends, Budget Allocation, Regulations, Acquisitions, Competitive Landscape and Forecast to 2029
Egypt Defense Market - Size and trends, budget allocation, regulations, key acquisitions, competitive landscape and forecast, 2024-2029 report provides the market size forecast and the projected growth rate for the next five years. The report covers industry analysis including the key market drivers, emerging technology trends, and major challenges faced by market participants. It also offers insights regarding key factors and government programs that are expected to influence the demand for military platforms over the forecast period. Egyptian defense and...